Shockwave Therapy TPS as a promising Alzheimer’s therapy on RTL on World Alzheimer’s Day
RTL Aktuell: New therapies for Alzheimer’s patients – hope for millions affected
That the shock wave therapy Transcranial Pulse Stimulation (TPS) is currently one of the most promising and helpful treatment methods for Alzheimer’s patients, we know in my practice for a long time. I have also already been interviewed by RTL about TPS therapy, where one of my patients, Jochen Vieregge with his wife Erika, also reported on his therapy success (see this: https://www.rtl.de/cms/hoffnung-fuer-alzheimer-kranke-neue-stosswellen-therapie-bringt-jochens-gedaechtnis-zurueck-4866225.html )
Further interview with my patient Jochen Vieregge and me planned
The feature on TPS therapy with me had been filmed and aired by RTL in November 2021. My patient Jochen Vieregge is still doing just as well today, almost two years later, thanks to regular booster treatments! To prove this, there will soon be another interview with Jochen and Erika and me in my Hamburg practice. But back to the new feature on World Alzheimer’s Day on Thursday, September 21, 2023:
RTL interviews renowned researcher Prof. Ullrich Wüllner from the University of Bonn about TPS
RTL has now put shock wave therapy TPS at the center of hope for the millions of patient:in as part of World Alzheimer’s Day 2023. Thus, the channel reported in several formats, including the main news “RTL Aktuell”, about those two new therapy options for Alzheimer’s dementia, which are currently the most talked about: The shock wave brain stimulation procedure Transcranial Pulse Stimulation (TPS) and anti-body medications such as Lecanemab.
RTL broadcast on this topic from the Neurocenter of the University Hospital Bonn (UBK) and interviewed my colleague, the renowned researcher Prof. Dr. med. Ullrich Wüllner, Director of the Clinic for Neurodegenerative Diseases, and also let a patient and his partner have their say in this report.
Prof. Wüllner and his team are researching transcranial pulse stimulation and see Alzheimer’s shock wave therapy as a good treatment option for Alzheimer’s patients: In the case of the interviewed patient, for example, the symptoms of Alzheimer’s disease have improved significantly; he and his partner speak of a miracle.
Alzheimer’s shock wave therapy TPS: stable course, patient feels “like new”
Prof. Wüllner emphatically summarizes in the interview, “We actually observe a stable course in two-thirds of our patients. That is, mental performance, as measured by neurological testing, does not get worse!”
At the German Center for Neurodegenerative Diseases (DZNE) Research Center in Bonn, research is also being conducted on new antibody drugs such as lecanemab as part of clinical trials. With some Patient:innen, however, it comes to severe side effects such as brain hemorrhages. The current aim is to find out which patients could benefit from the antibody therapy, the preparations of which have not yet been approved in Europe. Prof. Wüllner: “We need more personalized medicine. The anti-bodies don’t work the same for every affected person.”
New therapies can significantly improve the lives of many Alzheimer’s patients
Of course, all promising new therapies still need to be studied in large clinical trials. But with early diagnosis and treatment options such as shock wave therapy transcranial pulse stimulation, the lives of many Alzheimer’s patients:in the future may be significantly improved, according to the report.
The following link leads to the article in the news program “RTL Aktuell” from September 21, 2023:
https://www.rtl.de/videos/neue-therapien-fuer-alzheimer-patienten-650bd3e0ab000afd800cf564.html
